- Joined
- Sep 22, 2008
- Messages
- 84,689
- Points
- 113
Pfizer expensive anti viral drug works the same way as ivermectin but costs thousand more
- Thread starter syed putra
- Start date
- Joined
- Jan 16, 2014
- Messages
- 7,029
- Points
- 113
its about the money....from day 1 of this 'pandemic'
- Joined
- Jan 16, 2014
- Messages
- 7,029
- Points
- 113
rainy season here and winter in the north, next few months will be critical how this stupid virus mutates,
only thing we can do, stay trim and fit, avoid indoors crowded areas,
but those taking public transport, easier said than done, hope the sun comes out more
only thing we can do, stay trim and fit, avoid indoors crowded areas,
but those taking public transport, easier said than done, hope the sun comes out more
- Joined
- Jan 2, 2013
- Messages
- 7,062
- Points
- 113
Pfizer has unleashed its army of drug peddlars to spread online propaganda on how different their expensive drug is.
- Joined
- Jun 27, 2018
- Messages
- 31,020
- Points
- 113
https://www.news.com.au/lifestyle/h...t/news-story/e100ee9f0ecaf22ec515936b952f2fdb
Merck Covid-19 pill may not be as effective as thought
Britain on Thursday became the first country in the world to approve the ... more
View more related videos
Pharmaceutical giant Merck said Friday that its Covid-19 pill could be less effective than originally thought.
The drugmaker said the experimental pill, molnupiravir, was shown to be 30 per cent effective in fighting hospitalisations and deaths in a study of 1433 patients.
That’s a drop from a 50 per cent effectiveness rate in a prior study of 775 patients, the NY Post reported.
By contrast, a Pfizer Covid-19 pill showed an 89 per cent efficacy rate among 1200 patients who took the drug, paxlovid.
Friday’s announcement drove stock prices down by 3.9 per cent to $US79.12 in afternoon trading.
Merck released its latest results as the Food and Drug Administration considers approving the pill.
The FDA posted its analysis ahead of a meeting next week where an expert panel will weigh the evidence.
Merck Covid-19 pill may not be as effective as thought
Britain on Thursday became the first country in the world to approve the ... more
View more related videos
Pharmaceutical giant Merck said Friday that its Covid-19 pill could be less effective than originally thought.
The drugmaker said the experimental pill, molnupiravir, was shown to be 30 per cent effective in fighting hospitalisations and deaths in a study of 1433 patients.
That’s a drop from a 50 per cent effectiveness rate in a prior study of 775 patients, the NY Post reported.
By contrast, a Pfizer Covid-19 pill showed an 89 per cent efficacy rate among 1200 patients who took the drug, paxlovid.
Friday’s announcement drove stock prices down by 3.9 per cent to $US79.12 in afternoon trading.
Merck released its latest results as the Food and Drug Administration considers approving the pill.
The FDA posted its analysis ahead of a meeting next week where an expert panel will weigh the evidence.
Similar threads
